Key result
Continuous glucose monitoring time above range is linked to ~6% higher incident type 2 diabetes risk.
Cohort (n=499)
Answers are grounded in this paper and cite their sources.
Aim: To investigate the prognostic value of time range metrics, as measured by continuous glucose monitoring, with respect to the development of type 2 diabetes (T2D). Research design and methods: A total of 499 persons without diabetes from the general population were followed-up for 5 years. Time range metrics were measured at the start and medical records were checked over the period study. Results: Twenty-two subjects (8.3 per 1,000 person-years) developed T2D. After adjusting for age, gender, family history of diabetes, body mass index and glycated hemoglobin concentration, multivariate analysis revealed 'time above range' (TAR, i.e., with a plasma glucose concentration of >140 mg/dL) to be significantly associated with a greater risk (OR = 1.06, CI 1.01-1.11) of developing diabetes (AUC = 0.94, Brier = 0.035). Conclusions: Time above range provides additional information to that offered by glycated hemoglobin to identify patients at a higher risk of developing type 2 diabetes in a population-based study.
No takes yet. Share an insight, caveat, or question.
Marco et al. (2022) conducted a cohort in Type 2 diabetes risk (n=499). Time above range (>140 mg/dL) on continuous glucose monitoring was evaluated on Development of type 2 diabetes (OR 1.06, 95% CI 1.01-1.11). Time above range on continuous glucose monitoring was associated with a higher risk of developing type 2 diabetes over 5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: